Durect Posts Narrower Loss in Fiscal Q2
Durect ( NASDAQ:DRRX ) , a biopharmaceutical company focused on liver disease therapeutics, released results for the second quarter of fiscal 2025 on August 12, 2025. Durect posted better-than-expected earnings per share ( GAAP ) of $ ( 0.07 ) , surpassing analyst forecasts of $ ( 0.13 ) ( GAAP ) ...
This Palvella Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Almonty Indus ( NASDAQ:ALM ) , Adagene ( NASDAQ:ADAG )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
All You Need to Know About Indivior ( INDV ) Rating Upgrade to Strong Buy
Indivior (INDV) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Best Momentum Stock to Buy for August 5th
FFIV, INDV and NVT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 5, 2025.
New Strong Buy Stocks for August 5th
ARMN, QUAD, NVST, INDV and BJRI have been added to the Zacks Rank #1 (Strong Buy) List on August 5, 2025.
Indivior ( INDV ) Q2 EPS Jumps 104%
Indivior ( NASDAQ:INDV ) , a global pharmaceutical company known for its treatments for opioid use disorder ( OUD ) , reported results on July 31, 2025. The main news was a sharp outperformance compared to analyst estimates, with non-GAAP EPS of $0.51 beating the $0.25 consensus.
Roblox, Carvana, eBay, C.H. Robinson Worldwide, Huntington Ingalls Industries And Other Big Stocks Moving Higher On Thursday - Alnylam Pharmaceuticals ( NASDAQ:ALNY ) , AGCO ( NYSE:AGCO )
U.S. stocks were higher, with the Nasdaq Composite gaining around 150 points on Thursday. Shares of Roblox Corporation RBLX rose sharply during Thursday's session after the company reported better-than-expected second-quarter sales results and raised its FY25 sales guidance.
Indivior PLC ( INDV ) Tops Q2 Earnings and Revenue Estimates
Indivior (INDV) delivered earnings and revenue surprises of +96.15% and +22.05%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BioCryst Pharmaceuticals ( BCRX ) Reports Next Week: Wall Street Expects Earnings Growth
BioCryst (BCRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Indivior PLC ( INDV ) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Indivior (INDV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Indivior ( INDV ) Moves 5.7% Higher: Will This Strength Last?
Indivior (INDV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine Neurodevelopmental Disorder Programs
Geneva, Switzerland - June 30, 2025 - STALICLA SA, a Geneva-based clinical-stage biotech company pioneering precision medicine for neurodevelopmental and neuropsychiatric disorders, today announced the successful closing of a CHF 2 million financing led by Addex Therapeutics.
Addex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric Disorders
Ad Hoc Announcement Pursuant to Art. 53 LR ...
IGC Pharma, Inc. ( IGC ) Reports Q4 Loss, Beats Revenue Estimates
IGC Pharma, Inc. (IGC) delivered earnings and revenue surprises of +50.00% and +6.45%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Addex Shareholders Approve All Resolutions at Annual General Meeting
Ad Hoc Announcement Pursuant to Art. 53 LR ...
Strength Seen in Nektar ( NKTR ) : Can Its 12.1% Jump Turn into More Strength?
Nektar (NKTR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update
Ad Hoc Announcement Pursuant to Art. 53 LR ...
Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025
Geneva, Switzerland, June 18, 2025 - Addex Therapeutics ( SIX/NASDAQ: ADXN ) , a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that it will issue its Q1 2025 Financial Results ...
Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models
Ad Hoc Announcement Pursuant to Art. 53 LR ...
Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference
Geneva, Switzerland, June 5, 2025 - Addex Therapeutics ( SIX/NASDAQ: ADXN ) , a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that preclinical data from its gamma-aminobutyric ...
Addex Convenes Annual General Meeting 2025
Geneva, Switzerland, June 3, 2025 - Addex Therapeutics ( SIX: ADXN and Nasdaq: ADXN ) , a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that its 2025 Annual General Meeting will ...
Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies
Ad Hoc Announcement Pursuant to Art. 53 LR ...
Addex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery
Ad Hoc Announcement Pursuant to Art. 53 LR ...
Addex Reports Full Year 2024 Financial Results and Provides Corporate Update
Ad Hoc Announcement Pursuant to Art. 53 LR ...
Indivior ( INDV ) Q1 2025 Earnings Call
Image source: The Motley Fool.Thursday, Apr 24, 2025Mark Crossley: Chief Executive OfficerContinue reading ...
Indivior PLC ( INDV ) Q1 Earnings and Revenues Beat Estimates
Indivior (INDV) delivered earnings and revenue surprises of 86.36% and 11.51%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149
Ad Hoc Announcement Pursuant to Art. 53 LR ...
Plus Therapeutics ( PSTV ) Reports Q4 Loss, Misses Revenue Estimates
Plus (PSTV) delivered earnings and revenue surprises of -31.37% and 6.49%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
European Addiction-Focused Indivior Stock Falls As Drugmaker Warns Lower Revenues In 2025 Despite Q4 Earnings Beat - Indivior ( NASDAQ:INDV )
Indivior expects 2025 revenue of $955M-$1.025B, missing the $1.09B consensus, with adjusted EBIT guidance of $185M-$225M. Sublocade sales rose 10% to $194M, while Suboxone Film's market share fell to 15.2% from 18.4% due to rising generic competition.
Indivior PLC ( INDV ) Q4 Earnings Meet Estimates
Indivior (INDV) delivered earnings and revenue surprises of 0% and 13.98%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Indivior PLC ( INDV ) to Report a Decline in Earnings: What to Look Out for
Indivior (INDV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Addex to Present at the 2025 Swiss Equities Baader Conference
Geneva, Switzerland, January 8, 2025 - Addex Therapeutics ( SIX/NASDAQ: ADXN ) , a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that Dr Robert Lütjens, Head of Discovery - ...
Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Ad Hoc Announcement Pursuant to Art. 53 LR ...
Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024
Nine-month Results Remain On Track for Net Profit ...
Indivior PLC ( INDV ) Surpasses Q3 Earnings and Revenue Estimates
Indivior (INDV) delivered earnings and revenue surprises of 38.46% and 1.57%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Tesla, A. O. Smith And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Tesla ( NASDAQ:TSLA )
U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Friday. Shares of Tesla, Inc. TSLA fell sharply in today's pre-market trading on brokerage firm Robinhood after the company's robotaxi unveiling event late on Thursday failed to give investors' confidence.
S&P Moves Lower; Domino's Pizza Posts Mixed Q3 Results - BloomZ ( NASDAQ:BLMZ ) , Domino's Pizza ( NYSE:DPZ )
U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.3% on Thursday. The Dow traded down 0.36% to 42,360.40 while the NASDAQ fell 0.20% to 18,255.32. The S&P 500 also fell, dropping, 0.33% to 5,772.71. Energy shares jumped by 1.1% on Thursday.
Crude Oil Surges 3%; Delta Air Lines Posts Downbeat Earnings - LSB Industries ( NYSE:LXU )
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 0.1% on Thursday. The Dow traded down 0.17% to 42,437.66 while the NASDAQ rose 0.12% to 18,313.25. The S&P 500 also fell, dropping, 0.05% to 5,789.32. Energy shares jumped by 0.6% on Thursday.
Why Indivior Shares Are Diving Premarket On Thursday - Indivior ( NASDAQ:INDV )
Indivior PLC INDV shares are trading lower after the company reported preliminary third-quarter revenue results and cut its FY24 net revenue guidance below estimates. The company expects third-quarter net revenue of $302 million - $309 million versus the consensus of $289.37 million.
Indivior PLC Investors: Please contact the Portnoy Law Firm to recover your losses. October 1, 2024 Deadline to file Lead Plaintiff Motion
LOS ANGELES, Sept. 30, 2024 ( GLOBE NEWSWIRE ) -- The Portnoy Law Firm advises Indivior PLC ( "Indivior" or the "Company" ) INDV investors of a class action representing investors that bought securities between February 22, 2024 and July 8, 2024, inclusive ( the "Class Period" ) .
Investors who lost money on Indivior PLC ( INDV ) should contact Levi & Korsinsky about pending Class Action - INDV - Indivior ( NASDAQ:INDV )
NEW YORK, Sept. 30, 2024 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Indivior PLC ( "Indivior" or the "Company" ) INDV of a class action securities lawsuit.
DEADLINE ALERT for ABR, FIVE, DXC, and INDV: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Arbor Realty Trust ( NYSE:ABR ) , DXC Technology ( NYSE:DXC )
LOS ANGELES, Sept. 30, 2024 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update
Ad Hoc Announcement Pursuant to Art. 53 LR ...
INDV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Indivior PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Indivior ( NASDAQ:INDV )
NEW YORK, Sept. 29, 2024 ( GLOBE NEWSWIRE ) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Indivior PLC ( "Indivior" or "the Company" ) INDV and certain of its officers.
INDV DEADLINE NOTICE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Indivior PLC Investors with Losses in Excess of $100K to Secure Counsel Before Important October 1 Deadline in Securities Class Action - INDV - Indivior ( NASDAQ:INDV )
NEW YORK, Sept. 29, 2024 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Indivior PLC INDV between February 22, 2024 and July 8, 2024, both dates inclusive ( the "Class Period" ) , of the important October 1, 2024 lead ...
ROSEN, A LONGSTANDING LAW FIRM, Encourages Indivior PLC Investors to Secure Counsel Before Important October 1 Deadline in Securities Class Action - INDV - Indivior ( NASDAQ:INDV )
NEW YORK, Sept. 26, 2024 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Indivior PLC INDV between February 22, 2024 and July 8, 2024, both dates inclusive ( the "Class Period" ) , of the important October 1, 2024 lead ...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, CrowdStrike, DXC, and Five Below and Encourages Investors to Contact the Firm - CrowdStrike Holdings ( NASDAQ:CRWD ) , DXC Technology ( NYSE:DXC )
NEW YORK, Sept. 25, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Indivior PLC INDV, CrowdStrike Holdings, Inc.
DEADLINE ALERT for ABR, FIVE, INDV, DXC: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders - Arbor Realty Trust ( NYSE:ABR ) , DXC Technology ( NYSE:DXC )
BENSALEM, Pa., Sept. 25, 2024 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Rigel ( RIGL ) Surges 19.7%: Is This an Indication of Further Gains?
Rigel (RIGL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
ROSEN, A LEADING LAW FIRM, Encourages Indivior PLC Investors to Secure Counsel Before Important October 1 Deadline in Securities Class Action - INDV - Indivior ( NASDAQ:INDV )
NEW YORK, Sept. 23, 2024 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Indivior PLC INDV between February 22, 2024 and July 8, 2024, both dates inclusive ( the "Class Period" ) , of the important October 1, 2024 lead ...
